Cargando…
Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
The role of ROS and RNS is a long-standing debate in cancer. Increasing the concentration of ROS reaching the toxic threshold can be an effective strategy for the reduction of tumor cell viability. On the other hand, cancer cells, by maintaining intracellular ROS concentration at an intermediate lev...
Autores principales: | Calvani, Maura, Subbiani, Angela, Vignoli, Marina, Favre, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942895/ https://www.ncbi.nlm.nih.gov/pubmed/31934266 http://dx.doi.org/10.1155/2019/6346529 |
Ejemplares similares
-
β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation
por: Pasha, Amada, et al.
Publicado: (2021) -
β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment
por: Calvani, Maura, et al.
Publicado: (2020) -
Current Therapies and New Targets to Fight Melanoma: A Promising Role for the β3-Adrenoreceptor
por: Filippi, Luca, et al.
Publicado: (2020) -
β3-Adrenoreceptor Activity Limits Apigenin Efficacy in Ewing Sarcoma Cells: A Dual Approach to Prevent Cell Survival
por: Pasha, Amada, et al.
Publicado: (2019) -
β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance
por: Calvani, Maura, et al.
Publicado: (2020)